Two members of Maine's congressional delegation criticized a decision Friday by President Donald Trump to eliminate protections for transgender patients.
Sen. Susan Collins said Saturday in a tweet that the decision, which overturns an Obama-era protection against healthcare discrimination, was “simply wrong.”
The Trump Administration‘s decision to eliminate protections for transgender patients is simply wrong. I’ll work to overturn this discriminatory policy.
— Sen. Susan Collins (@SenatorCollins) June 13, 2020
On Friday, U.S. Rep Chellie Pingree tweeted that the reversal was “shameful.”
“No one should fear seeking health care because they may be discriminated against based on who they are or the care they need,” Pingree wrote. “I’ll keep fighting this Admin’s bigoted attacks on LGBTQ people.”
The Trump Admin’s unlawful roll back of transgender health protections is shameful. No one should fear seeking health care because they may be discriminated against based on who they are or the care they need. I’ll keep fighting this Admin's bigoted attacks on LGBTQ people. https://t.co/Z9bZaNCoyh
— Congresswoman Chellie Pingree (@chelliepingree) June 12, 2020
On Friday, the Trump administration finalized a rule that overturns Obama-era protections for transgender people against sex discrimination in health care. The Department of Health and Human Services said it will enforce sex discrimination protections “according to the plain meaning of the word ‘sex’ as male or female and as determined by biology,” rewriting an Obama-era regulation that sought a broader understanding shaped by a person’s internal sense of being male, female, neither or a combination.
The decision has been met with support from social conservatives, who opposed the Obama Administration’s prior policy change.
LGBTQ advocates have decried Trump’s move, saying explicit that transgender patients need explicit protections in order to seek sex-reassignment treatment, but also in order to receive basic care for common illnesses such as diabetes or heart problems.
As of Saturday afternoon, neither Sen. Angus King nor U.S. Rep. Jared Golden has issued any statements about the Trump administration’s decision.
The Associated Press contributed to this report.